Henan University of Chinese Medicine.
The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou, Henan Province, P.R. China.
Medicine (Baltimore). 2021 Jan 8;100(1):e23474. doi: 10.1097/MD.0000000000023474.
Previous studies have reported that rehabilitation training combined acupuncture (RTA) can be used for the treatment of limb hemiplegia (LH) caused by cerebral infarction (CI). However, its effectiveness is still unclear. In this systematic review study, we aim to evaluate the effectiveness and safety of RTA for LH following CI.
We will retrieve the databases of CENTRAL, EMBASE, MEDILINE, CINAHL, AMED, CBM, PUBMED, and CNKI from inception to June 1, 2020 with no language restrictions. The randomized controlled trials of RTA for evaluating effectiveness and safety in patients with LH following CI will be included. Cochrane risk of bias tool will be used to measure the methodological quality for all included studies. Two authors will independently select the studies, extract the data, and assess the methodological quality of included studies. A third author will be invited to discuss if any disagreements exist between 2 authors. We will perform heterogeneity assessment before carrying out meta-analysis. According to the heterogeneity, we select random effect model or fixed effect model for meta-analysis of the included cohort studies. Cochrane risk of bias tool will be used to determine the methodological quality for included studies. RevMan 5.3 software (Cochrane Community, London, UK) will be utilized to perform statistical analysis.
This systematic review will assess the effectiveness and safety of RTA for LH caused by CI. The primary outcome includes limbs function, as measured by the Wolf Motor Function Test (WMFT) Assessment scale, or other associated scales. The secondary outcomes consist of muscle strength, muscle tone, quality of life, and any adverse events.
The findings of this study will summarize the current evidence of RTA for LH caused by CI, and may provide helpful evidence for the clinical treatment.
The findings of this study are expected to be published in peer-reviewed journals. It does not require ethical approval, because no individual data will be utilized in this study.
INPLASY202070114.
既往研究报道康复训练联合针刺(RTA)可用于治疗脑梗死(CI)所致的肢体偏瘫(LH),但其疗效仍不明确。本系统评价旨在评估 RTA 治疗 CI 后 LH 的有效性和安全性。
我们将对 CENTRAL、EMBASE、MEDILINE、CINAHL、AMED、CBM、PUBMED 和中国知网(CNKI)数据库进行检索,检索时间为建库至 2020 年 6 月 1 日,不设语言限制。纳入 RTA 治疗 CI 后 LH 的有效性和安全性评估的随机对照试验。采用 Cochrane 偏倚风险工具评价所有纳入研究的方法学质量。两位作者独立筛选研究、提取数据并评价纳入研究的方法学质量。若 2 位作者存在分歧,则邀请第 3 位作者讨论。我们将在进行荟萃分析前评估异质性。根据异质性,我们选择随机效应模型或固定效应模型进行纳入队列研究的荟萃分析。采用 Cochrane 偏倚风险工具评价纳入研究的方法学质量。使用 RevMan 5.3 软件(Cochrane 协作网,英国伦敦)进行统计分析。
本系统评价将评估 RTA 治疗 CI 所致 LH 的有效性和安全性。主要结局指标包括 Wolf 运动功能测试(WMFT)评估量表或其他相关量表评估的肢体功能。次要结局指标包括肌肉力量、肌肉张力、生活质量和任何不良反应。
本研究的结果将总结目前 RTA 治疗 CI 所致 LH 的证据,可为临床治疗提供有价值的证据。
本研究的结果预计将发表在同行评议的期刊上。由于本研究不使用个体数据,因此不需要伦理批准。
INPLASY202070114。